Chapter 1.   DRUG DISCOVERY OUTSOURCING MARKET   – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2.   DRUG DISCOVERY OUTSOURCING MARKET    – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

 2.3.1. Impact during 2023 - 2030

  2.3.2. Impact on Supply – Demand

Chapter 3.   DRUG DISCOVERY OUTSOURCING MARKET    – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4.   DRUG DISCOVERY OUTSOURCING MARKET  - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5.   DRUG DISCOVERY OUTSOURCING MARKET   - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. DRUG DISCOVERY OUTSOURCING MARKET – By Drug Discovery Outsourcing Workflow

6.1. Target Identification & Screening

6.2. Target Validation & Functional Informatics

6.3. Lead Identification & Candidate Optimization

6.4. Preclinical Development

6.5. Other Associated Workflow

Chapter 7.  DRUG DISCOVERY OUTSOURCING MARKET     – By Drug Discovery Outsourcing Therapeutics Area

7.1. Respiratory system

7.2. Pain and Anesthesia

7.3. Oncology

7.4. Ophthalmology

7.5. Hematology

7.6. Cardiovascular

7.7. Endocrine

7.8. Gastrointestinal

7.9. Immunomodulation

7.10. Anti-infective

7.11. Central Nervous System

7.12. Dermatology

7.13. Genitourinary System

Chapter 8.    DRUG DISCOVERY OUTSOURCING MARKET   – By Drug Discovery Outsourcing Drug Type

8.1. Small Molecules

8.2. Large Molecules (Biopharmaceuticals)

Chapter 9.    DRUG DISCOVERY OUTSOURCING MARKET   – By Drug Discovery Outsourcing Service Type

9.1. Chemistry Services

9.2. Biology Services

Chapter 10.    DRUG DISCOVERY OUTSOURCING MARKET   – By Drug Discovery Outsourcing End User

10.1. Pharmaceutical & Biotechnology companies

10.2. Academic Institutes

10.3. Others

Chapter 11.   DRUG DISCOVERY OUTSOURCING MARKET    – By Region

11.1. North America

11.2. Europe

11.3. Asia-P2acific

11.4. Latin America

11.5. The Middle East

11.6. Africa

Chapter 12.   DRUG DISCOVERY OUTSOURCING MARKET    – By Companies

12.1. Companies 1

12.2. Companies 2

12.3. Companies 3 

12.4. Companies 4

12.5. Companies 5

12.6. Companies 6

12.7. Companies 7

12.8. Companies 8

12.9. Companies 9

12.10. Companies 10